Please select the option that best describes you:

Do you adjust the dose of ruxolitinib in primary myelofibrosis based on hemoglobin?  



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Massachusetts General Hospital
I agree with Dr. @Aaron T. Gerds. In addition, the...
Sign in or Register to read more